Finnrick - Ensuring a Safer and More Transparent Supply Chain
Shandong Aishi Biotechnology

Shandong Aishi Biotechnology

Tirzepatide

Finnrick tested 7 samples of Tirzepatide (GLP-1 and GIP agonist) from Shandong Aishi Biotechnology between 5 Dec 2024 and 6 Dec 2025. Test scores average over 4, no score below 3, and at least 6 tests warrant a confident Finnrick Rating of D (Poor).

Finnrick Rating™
Shandong Aishi Biotechnology
Tirzepatide
Tested 7 Samples
Last test 6 Dec 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Shandong Aishi Biotechnology

Samples are tested in commercial labs

Tests Count

7

Scores

AVG7.3MIN3.5MAX10.0

Last

6 Dec 2025

First

5 Dec 2024
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
6 Dec 2025View10.050mg51.2mg+2.4%99.95%sep,15.2025No Label / Silver Crimp / Red CapLab EPublic
25 Nov 2025View8.060mg61.1mg+1.8%99.95%(no batch ID)No Label / Silver Crimp / Red Cap Lab EPublic
5 Nov 2025View5.230mg35.53mg+18.4%99.90%(no batch ID)No Label / Copper Crimp / Clear CapLab GPublic
4 Nov 2025View10.020mg19.8mg-1.0%99.95%Sep 15, 2025No Label / Silver Crimp / Violet CapLab EPublic
29 Oct 2025View6.75mg5.06mg+1.2%99.37%(no batch ID)No Label / Silver Crimp / Blue CapLab EPublic
6 Oct 2025View3.530mg37.5mg+25.0%99.30%(no batch ID)No Label / Silver Crimp / Pink Cap Lab GPublic
5 Dec 2024View7.830mg29.6mg-1.3%99.80%(no batch ID)No Label / Copper Crimp / Clear CapLab GPublic